top of page

Groups Feed

View groups and posts below.


This post is from a suggested group

What’s Sciatica? Let’s Break It Down


Ever heard of sciatica? It’s that painful, sometimes shocking sensation that radiates down your leg—from your lower back through your hip and thigh, maybe even to your foot. Let’s clarify what it is, what’s trending in its management, and the latest insights.


What Is Sciatica?

Sciatica happens when the sciatic nerve (your body’s longest nerve) gets squeezed or irritated. This nerve runs from your lower spine to your legs, so pressure on it can cause sharp, burning pain, numbness, or a “pins-and-needles” tingle. Most often, it’s triggered by a herniated (slipped) disc pressing on the nerve, but spinal narrowing (stenosis) or muscle tightness in the buttocks (like piriformis syndrome) can also be culprits.


Symptoms to Watch For

Typically, you’ll feel pain down one leg (not both). It might start in your lower back, then shoot into your hip, thigh, and even foot. Coughing, sneezing,…


This post is from a suggested group

Therapeutic Optimization, Cardiovascular Guidelines & Patient Care Needs Driving the ACE Inhibitors Market

The ACE Inhibitors Market remains essential in cardiovascular and renal medicine, supporting management of hypertension, heart failure, diabetic nephropathy, and post-MI recovery. ACE inhibitors improve vascular function and slow disease progression, making them foundational therapy in global cardiac guidelines.


Despite competition from ARBs and newer drug classes, ACE inhibitors maintain strong adoption due to proven efficacy, favorable pricing, and widespread clinical familiarity.

Market stability is reinforced by chronic disease prevalence, aging populations, and improved screening programs. Generic availability supports affordability and adherence, especially in emerging markets. Fixed-dose combinations, patient-support programs, and hypertension-monitoring technology integration enhance therapy convenience and persistence.

FAQQ1: Primary indications?A1: Hypertension, heart failure, diabetic kidney disease, and post-MI care.Q2: Why sustained demand?A2: Clinical efficacy, affordability, and global guideline inclusion.

6 Views

This post is from a suggested group

August 11, 2025 · added a group cover image.
ree
15 Views

This post is from a suggested group

August 10, 2025 · updated the description of the group.

Welcome to the group! You can connect with other members, get updates and share ideas.

17 Views

Contact Terry for more details or support.

Terry Boettcher

Box 907

Two Hills County No. 21, AB T0B 4K0, Canada

780-603-0741

  • Facebook

Terry Boettcher - Division Three Councillor

 

© 2025 by Terry Boettcher for Division Three Councillor. Powered and secured by Wix

 

bottom of page